Skip to main content

Azitra, Inc.

AZTR
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001701478

No open-market purchases or sales by Azitra, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $3.26M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Azitra, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of AZTR: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders87−1
Shares596.3K137.2K−459.1K (−77.0%)
Value$58.5K$74.9K+$16.5K (+28.2%)

New holders (4)

Institutions that held Azitra, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AZTR in Q3 2024
InstitutionSharesValue% of portfolio
Warberg Asset Management LLC48,804$26.5K0.01%
Two Sigma Securities, LLC34,159$18.5K0.00%
Virtu Financial LLC21,314$12.0K0.00%
National Bank of Canada5,000$2.71K0.00%

Sold out (5)

Institutions that held Azitra, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AZTR in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Citadel Advisors LLC239,774$22.1K
HRT Financial LP136,296$12.0K
Knollwood Investment Advisory, LLC41,537$3.83K
Millennium Management LLC36,893$3.40K
XTX Topco Ltd33,056$3.05K